Aleix Prat-rekin lankidetzan egindako argitalpenak (1)
2018
-
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Journal of Clinical Investigation, Vol. 128, Núm. 9, pp. 3887-3905